Table 1. Baseline and tumor characteristics of patients before propensity score matching.

	TCM group (n = 523)	Control group (n = 294)	p value
age (y)
< 60	199	97	0.15
≥ 60	324	197
gender
male	274	161	0.51
female	249	133
location
colon	312	179	0.73
rectum	211	115
pathology
adenocarcinoma	461	236	0.01*
non-adenocarcinoma	4	2
unknown	58	56
histodifferentiation
poorly	52	29	0.01*
moderately	322	149
well	17	11
known	132	105
TNM stage
I	85	52	0.36
II	219	134
III	219	108
chemotherapy
yes	420	204	0.00*
no	103	90
radiotherapy
yes	38	17	0.42
no	485	277
comorbidities
yes	270	131	0.05
no	253	163

*statistical difference.